{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:15:28Z","timestamp":1762542928777},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"28","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2016-I2M-3-010"],"award-info":[{"award-number":["2016-I2M-3-010"]}]},{"name":"the Ministry of Science and Technology of People's Republic of China","award":["2017ZX09101003-002-004"],"award-info":[{"award-number":["2017ZX09101003-002-004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00216-018-1350-x","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T06:16:33Z","timestamp":1537856193000},"page":"7415-7428","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A UPLC\/MS\/MS method for comprehensive profiling and quantification of fatty acid esters of hydroxy fatty acids in white adipose tissue"],"prefix":"10.1007","volume":"410","author":[{"given":"Ting","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"issue":"2","key":"1350_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cell.2014.09.035","volume":"159","author":"MM Yore","year":"2014","unstructured":"Yore MM, Syed I, Moraes-Vieira PM, Zhang T, Herman MA, Homan EA, et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell. 2014;159(2):318\u201332. \n                    https:\/\/doi.org\/10.1016\/j.cell.2014.09.035\n                    \n                  .","journal-title":"Cell"},{"issue":"9","key":"1350_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrd.2016.75","volume":"15","author":"CM Kusminski","year":"2016","unstructured":"Kusminski CM, Bickel PE, Scherer PE. Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discov. 2016;15(9):639\u201360. \n                    https:\/\/doi.org\/10.1038\/nrd.2016.75\n                    \n                  .","journal-title":"Nat Rev Drug Discov"},{"key":"1350_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-015-0104-4","volume":"7","author":"Y Ma","year":"2015","unstructured":"Ma Y, Kind T, Vaniya A, Gennity I, Fahrmann JF, Fiehn O. An in silico MS\/MS library for automatic annotation of novel FAHFA lipids. J Cheminform. 2015;7:53. \n                    https:\/\/doi.org\/10.1186\/s13321-015-0104-4\n                    \n                  .","journal-title":"J Cheminform"},{"key":"1350_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.aca.2016.09.014","volume":"943","author":"MA L\u00f3pez-Basc\u00f3n","year":"2016","unstructured":"L\u00f3pez-Basc\u00f3n MA, Calder\u00f3n-Santiago M, Priego-Capote F. Confirmatory and quantitative analysis of fatty acid esters of hydroxy fatty acids in serum by solid phase extraction coupled to liquid chromatography tandem mass spectrometry. Anal Chim Acta. 2016;943:82\u20138. \n                    https:\/\/doi.org\/10.1016\/j.aca.2016.09.014\n                    \n                  .","journal-title":"Anal Chim Acta"},{"issue":"1","key":"1350_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrendo.2012.199","volume":"9","author":"VS Malik","year":"2013","unstructured":"Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol. 2013;9(1):13\u201327. \n                    https:\/\/doi.org\/10.1038\/nrendo.2012.199\n                    \n                  .","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"1350_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1042\/CS20150143","volume":"129","author":"L Zhao","year":"2015","unstructured":"Zhao L, Fu Z, Wu J, Aylor KW, Barrett EJ, Cao W, et al. Inflammation-induced microvascular insulin resistance is an early event in diet-induced obesity. Clin Sci. 2015;129(12):1025\u201336. \n                    https:\/\/doi.org\/10.1042\/CS20150143\n                    \n                  .","journal-title":"Clin Sci"},{"issue":"4","key":"1350_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/JCI10842","volume":"106","author":"BB Kahn","year":"2000","unstructured":"Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473\u201381. \n                    https:\/\/doi.org\/10.1172\/JCI10842\n                    \n                  .","journal-title":"J Clin Invest"},{"issue":"3","key":"1350_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1079\/PNS200194","volume":"60","author":"P Trayhurn","year":"2001","unstructured":"Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001;60(3):329\u201339.","journal-title":"Proc Nutr Soc"},{"issue":"3","key":"1350_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1079\/BJN20041213","volume":"92","author":"P Trayhurn","year":"2004","unstructured":"Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92(3):347\u201355.","journal-title":"Br J Nutr"},{"issue":"7","key":"1350_CR10","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.2337\/db16-0221","volume":"65","author":"PM Moraes-Vieira","year":"2016","unstructured":"Moraes-Vieira PM, Saghatelian A, Kahn BB. GLUT4 expression in adipocytes regulates de novo lipogenesis and levels of a novel class of lipids with antidiabetic and anti-inflammatory effects. Diabetes. 2016;65(7):1808\u201315. \n                    https:\/\/doi.org\/10.2337\/db16-0221\n                    \n                  .","journal-title":"Diabetes"},{"issue":"4","key":"1350_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nprot.2016.040","volume":"11","author":"T Zhang","year":"2016","unstructured":"Zhang T, Chen S, Syed I, St\u00e5hlman M, Kolar MJ, Homan EA, et al. A LC-MS\u2013based workflow for measurement of branched fatty acid esters of hydroxy fatty acids. Nat Protoc. 2016;11(4):747\u201363. \n                    https:\/\/doi.org\/10.1038\/nprot.2016.040\n                    \n                  .","journal-title":"Nat Protoc"},{"issue":"1-2","key":"1350_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0021-9673(96)00945-4","volume":"762","author":"JJ Kirkland","year":"1997","unstructured":"Kirkland JJ, Henderson JW, DeStefano JJ, van Straten MA, Claessens HA. Stability of silica-based, endcapped columns with pH 7 and 11 mobile phases for reversed-phase high-performance liquid chromatography. J Chromatogr A. 1997;762(1-2):97\u2013112.","journal-title":"J Chromatogr A"},{"issue":"12","key":"1350_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052454","volume":"7","author":"F Qu","year":"2012","unstructured":"Qu F, Wu CS, Hou JF, Jin Y, Zhang JL. Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide. PLoS One. 2012;7(12):e52454. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0052454\n                    \n                  .","journal-title":"PLoS One"},{"issue":"38","key":"1350_CR14","doi-asserted-by":"publisher","first-page":"9012","DOI":"10.1039\/c6ob01597b","volume":"14","author":"L Balas","year":"2016","unstructured":"Balas L, Bertrand-Michel J, Viars F, Faugere J, Lefort C, Caspar-Bauguil S, et al. Regiocontrolled syntheses of FAHFAs and LC-MS\/MS differentiation of regioisomers. Org Biomol Chem. 2016;14(38):9012\u201320. \n                    https:\/\/doi.org\/10.1039\/c6ob01597b\n                    \n                  .","journal-title":"Org Biomol Chem"},{"issue":"8","key":"1350_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135634","volume":"10","author":"LS Dalboge","year":"2015","unstructured":"Dalboge LS, Pedersen PJ, Hansen G, Fabricius K, Hansen HB, Jelsing J, et al. A hamster model of diet-induced obesity for preclinical evaluation of anti-obesity, anti-diabetic and lipid modulating agents. PLoS One. 2015;10(8):e0135634. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0135634\n                    \n                  .","journal-title":"PLoS One"},{"issue":"36","key":"1350_CR16","doi-asserted-by":"publisher","first-page":"15430","DOI":"10.1073\/pnas.0904944106","volume":"106","author":"E Fabbrini","year":"2009","unstructured":"Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106(36):15430\u20135. \n                    https:\/\/doi.org\/10.1073\/pnas.0904944106\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1350_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hep.22350","volume":"48","author":"D Poorten van der","year":"2008","unstructured":"van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48(2):449\u201357. \n                    https:\/\/doi.org\/10.1002\/hep.22350\n                    \n                  .","journal-title":"Hepatology"},{"issue":"7","key":"1350_CR18","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.amjcard.2010.11.023","volume":"107","author":"R Krysiak","year":"2011","unstructured":"Krysiak R, Gdula-Dymek A, Okopien B. Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia. Am J Cardiol. 2011;107(7):1010\u20138 e1. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2010.11.023\n                    \n                  .","journal-title":"Am J Cardiol"},{"issue":"3","key":"1350_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.diabres.2015.05.043","volume":"109","author":"MH Noureldein","year":"2015","unstructured":"Noureldein MH, Abd El-Razek RS, El-Hefnawy MH, El-Mesallamy HO. Fenofibrate reduces inflammation in obese patients with or without type 2 diabetes mellitus via sirtuin 1\/fetuin A axis. Diabetes Res Clin Pract. 2015;109(3):513\u201320. \n                    https:\/\/doi.org\/10.1016\/j.diabres.2015.05.043\n                    \n                  .","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"1350_CR20","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s00296-012-2613-z","volume":"33","author":"I Shirinsky","year":"2013","unstructured":"Shirinsky I, Polovnikova O, Kalinovskaya N, Shirinsky V. The effects of fenofibrate on inflammation and cardiovascular markers in patients with active rheumatoid arthritis: a pilot study. Rheumatol Int. 2013;33(12):3045\u20138. \n                    https:\/\/doi.org\/10.1007\/s00296-012-2613-z\n                    \n                  .","journal-title":"Rheumatol Int"},{"issue":"4","key":"1350_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5414\/CPP42212","volume":"42","author":"J Wysocki","year":"2004","unstructured":"Wysocki J, Belowski D, Kalina M, Kochanski L, Okopien B, Kalina Z. Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome. Int J Clin Pharmacol Ther. 2004;42(4):212\u20137.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1350_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1677\/joe.0.1740321","volume":"174","author":"M Furuhashi","year":"2002","unstructured":"Furuhashi M, Ura N, Murakami H, Hyakukoku M, Yamaguchi K, Higashiura K, et al. Fenofibrate improves insulin sensitivity in connection with intramuscular lipid content, muscle fatty acid-binding protein, and \u03b2-oxidation in skeletal muscle. J Endocrinol. 2002;174:321\u20139. \n                    https:\/\/doi.org\/10.1677\/joe.0.1740321\n                    \n                  .","journal-title":"J Endocrinol"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-018-1350-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-1350-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-1350-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T07:27:14Z","timestamp":1569396434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-018-1350-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":22,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1007\/s00216-018-1350-x","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"assertion":[{"value":"9 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}